Jane Wang
Technik-/Wissenschafts-/F&E-Leiter bei APOLLOMICS, INC.
Profil
Jane Wang currently works at Apollomics, Inc. (United States), as Chief Scientific Officer and Apollomics, Inc., as Chief Scientific Officer from 2023.
Dr. Wang also formerly worked at Pfizer Inc., as Principal and WuXi AppTec Co., Ltd., as Vice President-Medicinal Chemistry from 2010 to 2022.
Dr. Wang received her doctorate degree from the University of Maryland and undergraduate degree from Fudan University.
Aktive Positionen von Jane Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| APOLLOMICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.03.2023 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Jane Wang
| Unternehmen | Position | Ende |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 01.07.2022 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ausbildung von Jane Wang
| Fudan University | Undergraduate Degree |
| University of Maryland | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| APOLLOMICS, INC. | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
